(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.

Abstract:

:There has been increasing evidence that numerous bioactive dietary agents can hamper the process of carcinogenesis by targeting epigenetic alterations including DNA methylation. This therapeutic approach is considered as a significant goal for cancer therapy due to the reversible nature of epigenetic-mediated gene silencing and warrants further attention. One such dietary agent, green tea catechin, (-)-epigallocatechin-3-gallate (EGCG) has been shown to modulate many cancer-related pathways. Thus, the present study was designed to investigate the role of EGCG as an epigenetic modifier in HeLa cells. DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibition assays were conducted, and the transcription levels of DNMT3B and HDAC1 were assessed by enzymatic activity assay and RT-PCR, respectively. Furthermore, we studied the binding interaction of EGCG with DNMT3B and HDAC1 by molecular modeling as well as promoter DNA methylation and expression of retinoic acid receptor-β (RARβ), cadherin 1 (CDH1) and death-associated protein kinase-1 (DAPK1) in EGCG-treated HeLa cells by RT-PCR and MS-PCR. In the present study, time-dependent EGCG-treated HeLa cells were found to have a significant reduction in the enzymatic activity of DNMT and HDAC. However, the expression of DNMT3B was significantly decreased in a time-dependent manner whereas there was no significant change in HDAC1 expression. Molecular modeling data also supported the EGCG-mediated DNMT3B and HDAC1 activity inhibition. Furthermore, time-dependent exposure to EGCG resulted in reactivation of known tumor-suppressor genes (TSGs) in HeLa cells due to marked changes in the methylation of the promoter regions of these genes. Overall, the present study suggests that EGCG may have a significant impact on the development of novel epigenetic-based therapy.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Khan MA,Hussain A,Sundaram MK,Alalami U,Gunasekera D,Ramesh L,Hamza A,Quraishi U

doi

10.3892/or.2015.3802

subject

Has Abstract

pub_date

2015-04-01 00:00:00

pages

1976-84

issue

4

eissn

1021-335X

issn

1791-2431

journal_volume

33

pub_type

杂志文章
  • Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial.

    abstract::Insulin resistance (IR) is reportedly involved in the progression of hepatocellular carcinoma (HCC). Since neovascularization plays an important role in hepatocarcinogenesis and IR, an angiostatic therapy may be considered as one of the promising approaches for chemoprevention again...

    journal_title:Oncology reports

    pub_type: 杂志文章,随机对照试验

    doi:10.3892/or.2011.1433

    authors: Yoshiji H,Noguchi R,Ikenaka Y,Kaji K,Aihara Y,Yamazaki M,Yamao J,Toyohara M,Mitoro A,Sawai M,Yoshida M,Morioka C,Fujimoto M,Uemura M,Fukui H

    更新日期:2011-12-01 00:00:00

  • Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.

    abstract::Acquired chemoresistance refers to tumor cells gradually losing their sensitivity to anticancer drugs during the course of treatment, resulting in tumor progression or recurrence. This phenomenon, which has deleterious outcomes for the patient, has long been observed in patients with glioblastoma receiving temozolomid...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6322

    authors: Lin J,Zuo J,Cui Y,Song C,Wu X,Feng H,Li J,Li S,Xu Q,Wei W,Qiu G,He H

    更新日期:2018-05-01 00:00:00

  • TRAF4 promotes tumorigenesis of breast cancer through activation of Akt.

    abstract::Increasing evidence suggests that tumor necrosis factor receptor-associated factor 4 (TRAF4) is an oncogene which is frequently overexpressed in many human carcinomas. Although TRAF4 was originally identified in breast cancer, the underlying mechanism of TRAF4 in tumorigenesis remains largely unknown. In the present s...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3304

    authors: Zhang J,Li X,Yang W,Jiang X,Li N

    更新日期:2014-09-01 00:00:00

  • Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway.

    abstract::The peroxisome proliferator-activated receptor-γ (PPAR-γ) coactivator-1β (PGC-1β) is a well-established regulator of mitochondrial biogenesis. However, the underlying mechanism of PGC-1β action remains elusive. This study reveals that knockdown of endogenous PGC-1β by short-hairpin RNA (shRNA) leads to a decrease in t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2628

    authors: Wang L,Liu Q,Li F,Qiu J,Fan H,Ma H,Zhu Y,Wu L,Han X,Yang Z,Jiang H,Wei J,Xia H

    更新日期:2013-10-01 00:00:00

  • Contrasting effects of extended low dose versus standard dose shorter course UFT chemotherapy on microscopic versus macroscopic established tumors: implications for optimal postoperative adjuvant chemotherapy.

    abstract::Given such differences as relative tumor burden, the optimal dose and schedule for postoperative adjuvant chemotherapy of microscopic disease might be expected to differ significantly from therapy of advanced higher volume disease. We investigated this hypothesis by determining the optimal dose and schedule of the 5-F...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Uchida J,Okabe H,Nakano K,Fujioka A,Saito H,Sugimoto Y,Oka T,Fukushima M

    更新日期:2007-08-01 00:00:00

  • Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

    abstract::Cancer represents a significant challenge for humankind, as early diagnosis and treatment are difficult to achieve. To systemically investigate the effect of sex, body mass index (BMI) and age on cancer incidence and prognosis, the data from 14,504 cases of cancer were downloaded from The Cancer Genome Atlas (TCGA). B...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6529

    authors: Huang X,Shu C,Chen L,Yao B

    更新日期:2018-09-01 00:00:00

  • Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer.

    abstract::Although the impact of vascular endothelial growth factor (VEGF) is clearly established in advanced prostate cancer (PCa), its role in localized PCa remains to be determined. The aim of our study was to analyse the plasma levels of VEGF-A and the expression of VEGF-A in prostatic tissue in a population of patients wit...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Peyromaure M,Badoual C,Camparo P,Grabar S,Goulvestre C,Fulla Y,Vieillefond A,Mao K,Dinh-Xuan AT

    更新日期:2007-07-01 00:00:00

  • Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain.

    abstract::Primary and metastatic cancers that affect bones are frequently associated with severe and intractable pain. The mechanisms underlying the development of bone cancer pain are largely unknown. In the present study, we investigated whether inhibition of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3718

    authors: Cai J,Fang D,Liu XD,Li S,Ren J,Xing GG

    更新日期:2015-03-01 00:00:00

  • Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells.

    abstract::Despite the high response rates of small cell lung cancer (SCLC) to first-line cisplatin-based chemotherapies, most patients with SCLC will eventually experience disease progression. Accordingly, novel chemotherapeutic regimens are desired. This in vitro study was carried out in order to develop novel chemotherapeutic...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Takeda K,Suyama H,Igishi T,Shigeoka Y,Matsumoto S,Yamasaki A,Hashimoto K,Sumikawa T,Morita M,Ueda Y,Shimizu E

    更新日期:2008-04-01 00:00:00

  • Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.

    abstract::The development and progression of epithelial cancers are the result of an imbalance in signals promoting and inhibiting cellular proliferation and apoptosis. The aim of this study is to evaluate the expression of cell-cycle and apoptosis regulators and correlate them with clinical outcome in the most frequent carcino...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.14.6.1527

    authors: Abdulkader I,Sánchez L,Cameselle-Teijeiro J,Gude F,Chávez JE,López-López R,Forteza J,Fraga M

    更新日期:2005-12-01 00:00:00

  • Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC.

    abstract::Pancreatic cancer is usually diagnosed in the advanced stages and is sensitive to only few therapies. The forkhead box L1 (FOXL1) and protein phosphatase 2A (PP2A) have been recognized to be tumor suppressive in human pancreatic cancers. In the present study, we co-expressed the two tumor suppressive molecules with a ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4592

    authors: Li Y,Yu D,Sheng W,Song H,Li Y,Dong M

    更新日期:2016-04-01 00:00:00

  • Effects of miR‑181a on the biological function of multiple myeloma.

    abstract::The present study aimed to investigate the role of miR‑181a in multiple myeloma (MM) cell lines. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect the expression of microRNA (miR)‑181a. The MM cell line RPMI 8226 stably transduced with miR‑181a mimics or inhibitor was establishe...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7160

    authors: Liu N,Yang J,Yuan R,Peng J,Liu L,Guo X

    更新日期:2019-07-01 00:00:00

  • Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells.

    abstract::Minimal residual disease (MRD) is derived from tumor-initiating cells (TICs) and is responsible for tumor relapse. Neuroblastoma is characterized by extreme tumor heterogeneity, and more than half of high-risk patients experience tumor relapse. To overcome tumor heterogeneity and ac...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2286

    authors: Hartomo TB,Kozaki A,Hasegawa D,Van Huyen Pham T,Yamamoto N,Saitoh A,Ishida T,Kawasaki K,Kosaka Y,Ohashi H,Yamamoto T,Morikawa S,Hirase S,Kubokawa I,Mori T,Yanai T,Hayakawa A,Takeshima Y,Iijima K,Matsuo M,Nishio H

    更新日期:2013-04-01 00:00:00

  • MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is the most common form of adult liver cancer and accounts for approximately 90% of all cases of primary liver cancer annually. Rhotekin (RTKN), which functions as a cancer promoter, can be frequently detected in many human cancers, including gastric cancer, colorectal carcinoma and blad...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5290

    authors: Zhou J,Zhang Y,Qi Y,Yu D,Shao Q,Liang J

    更新日期:2017-02-01 00:00:00

  • MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.

    abstract::The roles and mechanisms of mini-chromosome maintenance complex component 7 (MCM7) amplification and overexpression in esophageal carcinogenesis were investigated. By analyzing the TCGA datasets, we found that MCM7 was amplified in approximately 12% of esophageal squamous cell carcinomas (ESCCs), and in more than 4% o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5614

    authors: Qiu YT,Wang WJ,Zhang B,Mei LL,Shi ZZ

    更新日期:2017-06-01 00:00:00

  • Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.

    abstract::Bee venom (BV) therapy is a type of alternative medical treatment used to treat various diseases in oriental medicine. The mechanisms underlying the effects of BV remain poorly understood. In the present study, we evaluated the antiviral effect of BV on cervical carcinoma cell lines (CaSki, HeLa, C33A and TC-1). BV tr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3760

    authors: Kim YW,Chaturvedi PK,Chun SN,Lee YG,Ahn WS

    更新日期:2015-04-01 00:00:00

  • Hepatitis B virus X protein modifies invasion, proliferation and the inflammatory response in an HTR-8/SVneo cell model.

    abstract::Mother-to-infant transmission of hepatitis B virus (HBV) can occur as an intrauterine, intrapartum or postpartum infection. In the present study, we induced a multifunctional viral regulator of HBV gene products, HBx, and its different fragments to overexpress in a tropho-blast cell line, HTR-8/SVneo. We then identifi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4172

    authors: Cui H,Li QL,Chen J,Na Q,Liu CX

    更新日期:2015-10-01 00:00:00

  • Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey.

    abstract::No information is currently available regarding pancreatic cancer (PC) pattern of care in Italy. In the present study, a nationwide survey using a questionnaire was performed to enquire the local standards for PC diagnosis and radiotherapy treatment. Fifty-seven percent of 140 Italian centres completed questionnaire. ...

    journal_title:Oncology reports

    pub_type: 杂志文章,多中心研究

    doi:10.3892/or.2015.3955

    authors: Macchia G,Sainato A,Talamini R,Boz G,Bacigalupo A,Caravatta L,Fiore M,Friso ML,Fusco V,Lupattelli M,Mantello G,Mattiucci GC,Slim N,Sciacero P,Turri L,Valentini V,Morganti AG,Genovesi D

    更新日期:2015-07-01 00:00:00

  • MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.

    abstract::Melanoma is the seventh most common malignancy in females and the fifth most common cancer in males worldwide. An increasing number of studies have reported that microRNA (miRNA) dysregulation is frequently observed in various types of human cancers, including melanoma. Abnormally expressed miRNAs play an important ro...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6074

    authors: Kang K,Zhang J,Zhang X,Chen Z

    更新日期:2018-01-01 00:00:00

  • A novel region of deletion on 13q33-q34 in esophageal squamous cell carcinoma.

    abstract::Chromosome 13 presents frequent allelic loss in esophageal squamous cell carcinomas (ESCC). However, no ESCC suppressor gene has been identified from this chromosome. To define common deletion regions that possibly contain the ESCC suppressor gene(s), we performed a mapping of allelic loss in 50 esophageal squamous ce...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Guo GM,Huang XP,Dong JT,Caia Y,Xu X,Han YL,Wu M,Zhan QM,Wang MR

    更新日期:2005-12-01 00:00:00

  • A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.

    abstract::The majority of patients with hormone receptor-positive metastatic breast cancer die from disease progression despite different types of anti-hormonal treatments. Preclinical studies have indicated that resistance to anti-hormonal therapies may be the result of an activated NF-κB si...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1562

    authors: Trinh XB,Sas L,Van Laere SJ,Prové A,Deleu I,Rasschaert M,Van de Velde H,Vinken P,Vermeulen PB,Van Dam PA,Wojtasik A,De Mesmaeker P,Tjalma WA,Dirix LY

    更新日期:2012-03-01 00:00:00

  • Chemotherapy under cachectic conditions and the possibility of cachexia-controlled chemotherapy.

    abstract::We studied the role of chemotherapy in cancer cachexia, which is well known to lower QOL and responsiveness to chemotherapy. In BALB/c mice we used two clones derived from the murine colon 26 adenocarcinoma cell line; clone 5, a non-cachexigenic tumor and clone 20, a cachexigenic tumor, in which IL-6 mRNA was selectiv...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Takahashi Y,Yasumoto K,Mai M

    更新日期:2005-07-01 00:00:00

  • Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.

    abstract::Hereditary multiple exostoses (HME) is an autosomal dominant bone disorder characterized by the presence of multiple benign cartilage-capped tumors. EXT1 located on chromosome 8q23-q24 and EXT2 located on 11p11-p12 are the main disease-causing genes which are responsible for ~90% of HME cases. Mutations of EXT1 or EXT...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2891

    authors: Cao L,Liu F,Kong M,Fang Y,Gu H,Chen Y,Zhao C,Zhang S,Bi Q

    更新日期:2014-02-01 00:00:00

  • MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.

    abstract::As a common malignancy of the endocrine system, papillary thyroid carcinoma (PTC) seriously affects the quality of life of patients. lncRNA PAX8‑AS1:28, or lnc‑PSD4‑1:14 has been reported to be abnormally expressed in PTC. However, the function of PAX8‑AS1:28 in PTC is still unknown. Therefore, the present study aimed...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.6996

    authors: Zhang Y,Li F,Chen J

    更新日期:2019-04-01 00:00:00

  • Multiparameter analysis using cell cycle biomarkers for small-size lung adenocarcinoma: prognostic implications.

    abstract::Cell cycle-related molecules play crucial roles in maintaining genomic stability, and can also serve as biomarkers of cell cycle phase distribution at the same time. In this study, we used multiparameter analysis of various biomarkers to investigate their utility for the evaluation ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1894

    authors: Haruki T,Shomori K,Shiomi T,Taniguchi Y,Nakamura H,Ito H

    更新日期:2012-09-01 00:00:00

  • Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?

    abstract::The abilities of 5,6-benzoflavone (5,6-BF, a synthetic flavonoid), indole-3-carbinol (I3C, a plant derived product) or diindolylmethane (DIM, a condensation product of I3C) to alter the induction of mammary cancers induced by the carcinogens 7,12-dimethylbenzanthracene (DMBA) or N-methyl-N-nitrosourea (MNU) were evalu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1316

    authors: Lubet RA,Heckman BM,De Flora SL,Steele VE,Crowell JA,Juliana MM,Grubbs CJ

    更新日期:2011-09-01 00:00:00

  • Hyperthermia-induced apoptosis in two rat yolk sac tumor cell lines with different radiothermosensitivity in vitro.

    abstract::We investigated cell susceptibility to hyperthermia-induced apoptosis in two rat yolk sac tumor cell lines (RYSTs) and attempted to correlate this with the known potentially relevant molecular determinants of apoptosis, p53 protein status, Bcl-2 family of proteins and heat shock proteins (Hsp). Parent cell line, NMT-1...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.3.501

    authors: Islam MS,Mitsuhashi N,Akimoto T,Sakurai H,Hasegawa M,Ishikawa H,Niibe H

    更新日期:2001-05-01 00:00:00

  • Regulation of apoptosis by p53-inducible transmembrane protein containing sushi domain.

    abstract::The tumor suppressor p53 is a transcription factor that induces the transcription of various target genes in response to DNA damage and it protects the cells from malignant transformation. In this study, we performed cDNA microarray analysis and found that the transmembrane protein containing sushi domain (TMPS) gene,...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000972

    authors: Cui H,Kamino H,Nakamura Y,Kitamura N,Miyamoto T,Shinogi D,Goda O,Arakara H,Futamura M

    更新日期:2010-11-01 00:00:00

  • Involvement of Mcl1 in diallyl disulfide-induced G2/M cell cycle arrest in HL-60 cells.

    abstract::Diallyl disulfide (DADS) has shown potential as a therapeutic agent in various cancers. Previously, we found that myeloid cell leukemia sequence 1 (Mcl1) was downregulated in DADS-induced cell cycle arrest in HL-60 human leukemia cells. Here, we investigated the role of this protein...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1704

    authors: Yi L,Ji XX,Tan H,Feng MY,Tang Y,Wen L,Su Q

    更新日期:2012-06-01 00:00:00

  • B7-H1 protein vaccine induces protective and therapeutic antitumor responses in SP2/0 myeloma-bearing mice.

    abstract::B7-H1 is a co-inhibitory molecule belonging to the B7 family. The B7-H1 protein is only expressed on macrophage lineage of cells in normal tissues, but is overexpressed in most types of tumor. The aberrant expression of cell surface B7-H1 on cancer cells is generally associated with high-risk prognostic factors. The t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2686

    authors: Zhang C,Wang W,Qin X,Xu Y,Huang T,Hao Q,Li W,Wu S,Zhang Y

    更新日期:2013-11-01 00:00:00